Acute myelofibrosis is often associated with acute megakaryoblastic leukemia (AMKBL). Although the exact mechanism for the progression of myelofibrosis in AMKBL is unclear, certain humoral factors from megakaryoblastic cells, the precursors of platelets, may be involved in the enhancement of collagen synthesis by bone marrow fibroblasts. The present study, therefore, is an investigation of the possible pathogenic role of transforming growth factorj3 (TGF-@). known t o be a very potent collagen-stimulating factor found in platelets in the myelofibrosis of AMKBL. The results obtained were as follows: (1) Conditioned media from peripheral megakaryoblasts taken from an AMKBL patient and from established megakaryoblast cell lines (MEG-01) had much greater stimulatory effects on collagen synthesis in bone marrow fibroblasts than conditioned media from other leukemic cell types. (2) Based on HE PROGNOSIS FOR patients with myelofibrosis is
an assessment of soft agar colony formation, there was greater TGF-B activity in media that had been conditioned from megakaryoblasts than in media from other leukemic cell types. (3) When compared with other leukemic-cell types, megakaryoblasts showed substantially greater expression of TGF-@ mRNA that was hybridized at 2.5 kb with a TGF-@ cDNA probe, and TGF-@ polypeptides were detected at 13 Kd with anti-TGF-8 antibodies. (4) The addition of the anti-TGF-j3 antibody inhibited the stimulatory effects of the megakaryoblast conditioned medium on collagen synthesis in bone marrow fibroblasts. These results clearly suggest that megakaryoblasts produce and secrete an active form of TGF-@ and stimulate collagen synthesis in bone marrow fibroblasts in a paracrine manner. 0 7990 by The American Society of Hematology.
become the prime candidates for consideration as this humoral factor. Nevertheless, as yet there have been no reports that have been able to prove directly the megakaryoblastic origin of a humoral factor in myelofibrosis advancement. The present research, therefore, is an investigation of growth factors; in particular, we studied the powerful transforming growth factor+ (TGF-P), which is known to stimulate collagen synthesis, and evaluated its role as a disease-causing factor.
MATERIALS AND METHODS

Megakaryoblastic leukemic cells and other leukemic cell types.
Five patients hospitalized from January 1987 through June 1988 in the Department of Internal Medicine (Section 4), Sapporo Medical College Hospital (Japan) were studied. The patients were diagnosed as follows on the basis of criteria by FAB classifi~ation~~~: one case of acute megakaryoblastic leukemia (FAB M7; AMKBL) and, for camparison, one case of acute myeloblastic leukemia (FAB M2; AML), one case of acute monocytic leukemia (FAB M5; AMoL); and two cases (labeled case 1 and case 2) of acute lymphocytic leukemia (FAB L1; ALL). From peripheral blood samples that had been obtained after consent of the patients, mononuclear cells were separated by Ficoll-Isopaque density gradient sedimentation. Blast cdls accounted for 91% of the peripheral mononuclear cells in the AMKBL case, 85% in the AML case, 90% in the AMoL case, 79% in ALL case 1, and 72% in ALL case 2. The blasts from AMKBL were positive for platelet peroxidase staining by electron microscopy and for glycoprotein IIb-IIIa (GPIIb-IIIa) staining. A detailed description of the symptoms of this case and the nature of the blast cells can be found in earlier reports. 6 Detailed properties of MEG-01 derived from AMKBL were reported elsewhere.' The K562 derived from human chronic myeloblastic leukemia was kindly provided by Mochida Industries (Tokyo, Japan), and the KM3 and REH from human ALL were provided by Section 1 of the Deprtment of Pathology, Sapporo Medical College Hospital.
As culturing media, RPMI 1640 and Dulbecco's modified Eagle's medium (DMEM) were purchased from the GIBCO Co (Grand Island, NY), and a-Modified Eagle's medium (a-MEM) was from Flow Laboratories (North Ryde, Australia). Fetal calf serum (FCS), also obtained from Flow Labs, was kept in an inactive state at 56°C for 30 minutes before use. Epidermal growth factor (EGF) was purchased from Wakunaga Pharmaceuticals, Osaka, Japan. The platel&-derived growth factor (PDGF), alkaline phosphatase, and T4 polynucleotidekinase were from Takara Distilleries, Kyoto, Japan, and the bacterial collagenase was from the Nitta Gelatin Co, Osaka, Japan. The Freund complete adjuvant was obtained from the DIFCO Co (Detroit, MI), and the Vecstatin ABC kit (No. 41-07-00) was from Vector Laboratories (Burlingame, CA).
Reagents.
As the medium to subculture-established leukemic cell lines, we used RPMI 1640 containing 10% FCS, 100 units/mL of penicitlin, and 100 pg/mL of kanamycin. The mixture was then cultured in a tissue culture flask (Falcon 3024; Becton-Dickinson Co) at a temperature of 37OC and in an atmosphere containing 5% COz.
Leukemia cells were suspended in the RPMI 1640 at a density of 5 x lo7 cells per milliliter. After incubation for 2 hours at 37OC and 5% CO,, the medium was centrifuged and the supernatant was collected for use as the conditioned medium. In the present experiments, the conditioned media were not acidified for activation.
Assay for TGF-@ activity (normal rat kidney colony formation). Thc. cultivation of normal rat kidney (NRK) fibroblasts on a soft agar medium followed the method of Roberts et a1.* To the 35-mm diameter of a six-well culturing plate (Falcon 3046, BectonDickinson), a basal layer of 1.0 mL DMEM in which 10% FCS had been mixed with 0.5% agar was added and hardened. To the layer above this basal layer, 9 x lo3 NRK fibroblasts in 1. 0 mL DMEM containing 0.3% agar, EGF (giving a final concentration of 2.5 ng/mL), and TGF-@ (giving final concentration of 1.0 ng/mL) or 0. 1 mL conditioned medium, was added and hardened. Culturing was continued for 7 days at 37OC and 5% CO,, and the colony number per well was measured.
We followed the method of Castro-Malaspina et a19 to culture bone marrow fibroblasts. Bone marrow was aspirated from the sternum of a normal individual, and a buRy coat was prepared to 5 x 10' bone marrow cells. At a bone marrow cell density of 5 x lo6 mL, the cells were suspended in a-MEM wtih 20% FCS, and cultured at 37OC and 5% CO,. After 2 weeks of cultivation, the bone marrow fibroblasts were found to adhere to the culture flask.
In carder to extract TGF-/3 from blood platelets, we used the method described by Assoian et a1.I' By centrifugation of 50 units of an enriched platelet suspension, 25 g of platelets was collected. From this platelet preparation, we obtained the soluble fraction in the acid-ethanol solution (93% ethanol, 0.23 mol/L HCL), and to it we added ethanokdiethyl ether (1:2) to get the precipitate fraction. Using a Bio-Gel P 60 column equilibrated in 1 mol/L acetic acid and subsequently Bio-Gel P 60 column equilibrated in 1 mol/L acetic acid and 8 mol/L urea. TGF-@ was chromatographically purified. The purity of TGF-/3 was such that a single band had a molecular weight of 12,500, as estimated by sodium dodecyl sulfatepolyacrylamide gel ebctrophoresis (SDS-PAGE).
We used the methodof Postlethwaite et all' to measure the ability of myelofibroblasts to synthesize collagen. Myelofibroblasts were cultured in a medium to which 3H-proline had been added. Protein secreted in the supernatant was precipitated in trichloroacetic acid (TCA), and the amount of 'H-proline incorporated in the entire protein fraction was measured. Once the protein in the supernatant had been sufficiently degraded with bacterial collagenase, it ylas precipitated with TCA, and the amount of 'H-proline incorporated in the collagenasenonsensitive fraction was ,measured. The amount of 3H-proline incorporated in the collagenase-sensitive fraction was calculated as the amount of 'H-proline incorporated in the entire protein fraction The amount of collagen synthesis in terms of total protein collagen synthesis (hereafter designated as the collagen synthesis rate) was calculated by means of the following equation (taken from Peterkofsky and Digelmann'*): % collagen synthesis rate = (collagenasesensitive fraction x 100)/(5.4 x collagenase-nonsensitive fraction + collagenase-sensitive fraction).
A l/lOth amount of each type of conditioned medium (CM) was added to a myelofibroblast suspension (1 x 104/mL) in a-MEM supplemented with 2% plasma-derived serum and was poured in 1 mL units into each of the 24 wells in a multiplate (16 mm in diameter, Falcon 3047, Becton Dickinson Co). The plate was then cultured at 37OC in an atmosphere containing 5% CO,. Cells were collected from the plate after 48,72, and 96 hours, and counted.
Northern blot hybridization. Using the method for guanidinium thiocyanate of Chirgwin et aI,l3 we extracted the total RNA fraction from the cells. mRNA was extracted on an Oligo-dT cellulose column (Collaborative Research Co, Bedford, MA) following the method of Aviv and Leder.14 TGF-@ cDNA was cloned from the KB cell cDNA library originating in human epidermoid carcinoma as in previous experiment^,'^,'^ and their EcoRI-Pst I breakage fragments (1572 bp) were used as probe. 5'-Terminal dephosphorylations and 5' terminal 32P-labeling were carried out by means of the method of Maniatis et al." The specific activity of the thus obtained "P-labeled TGF-/3 probe was 3 x lo5 cpm/pg.
After denaturing mRNA with glyoxal, 4pg mRNA per lane was electrophoresed by the method described by Thomas'' on horizontal 1.1% agarose gels (3 mm thick and 10 cm long), at 75V for 40 minutes, using a transblot electrophoresis apparatus (Trans Blot Apparatus; Bio-Rad Co). Glyoxalated mRNA was transferred from agarose to a nylon filter (Zeta-Probe Blotting Membrane; Bio-Rad Co). A filter was then submerged in a hybridization buffer, pH 7.0 (composed of 10% Dextran, 750 mmol/L NaCI, 75 mmol/L sodium citrate, 2% glycine, SO mmol/L sodium phosphate, 0.1% bovine serum albumen [BSA], 0.1% Ficoll, 0.1% polyvinyl pyrrolidone), to which "P-TGF-8 cDNA (5 x IOs cpm/mL) had been added, and incubated 24 hours at a temperature of 55OC. The fiIter was then washed and autoradiographed.
Using the method of Hopp and Woods" we postulated the antigenic determinants of the TGF-/3 polypeptide. The three highest mean hydrophilicitic values were judged the antigenic determinants. The amino acid sequences corresponding to these three regions are N1-15 (ALDTNYCF-SSTEKNC), N17-29 (VRQLYIDFRKDLG), and N92-103 (VGRKPKVEQLSN). Based on the method of Merrifield," the chemical syntheses of the peptides were performed by using a peptide synthesizer (Model 430A, Applied Biosystems), and the resulthg peptides were purified by high-speed liquid chromatography. The three types of synthetic peptides were then allowed to react with m-maleimidobenzoyl-N-hydroxy succinimid ester (MBS), and solidified on key-hole limpetes hemocyanin (KLH), using the method reported by Liu et a1."
The three types of KLH-bound peptides were each mixed with Freund's complete adjuvant and injected subcutaneously into six male New Zealand rabbits, each weighing 2 kg. Once biweekly, for a total of six times, antigen sensitization was carried out, and anti serum was obtained.
Using three partial synthetic peptides (Nl-19, N17-29, and N92-103), titer of anti-serum was examined by the double antibody method.
The 1251-labeling of the N1-15 and N17-29 peptides was done following Hunter's method.*' The specific activity of the '*51-N1-1 5
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For personal use only. on October 23, 2017. by guest www.bloodjournal.org From 1542 TERM ET AL peptide was 107.2 pCi/pg, while that of the 1251-N17-29 peptide was 137.5 pCi/pg.
For the peptide N92-103, which had no tyrosine residue, the method of Bolton and Hunter" was applied for the labeling. The specific activity of the '2s1-N92-103 peptide was 101.9 pCi/Mg.
The dilution of the anti-serum that sedimented 50% of the '251-labeled peptide was 5,500 times for the anti-Nl-15 serum, 13,000 times for the anti-N17-29 serum, and 11,000 times for the anti-N92-103 serum.
The extraction of the IgG fraction from anti-serum followed the method of Fahey and Terry.24 After having been precipitated in ammonium sulfate, the IgG fraction was subjected to diethyl aminoethyl (DEAE) cellulose column chromatography.
Immunostaining by Western blot was performed on three types of anti-sera, with the purified IgG as the primary antibody and extracted TGF-8 as the antigen. All three antibodies demonstrated a 13 Kd band, which would correspond to a TGF-8 subunit. Of these three antibodies, the N92-103 antibody dose-dependently suppressed TGF-8 activity (NRK colony forming activity; but anti-N1-15 antibody, anti-N17-29 antibody, or normal rabbit serum did not effect TGF-@ activity.
In order to extract TGF-8 from leukemia cells, we used the method described by Assoian et a1.I0The leukemia cells (1 x lo') were added to a solution of acidic ethanol prepared as described above and immediately extracted in a Dounce homogenizer. After incubation overnight at 4OC, precipitated proteins were removed by centrifugation; crude TGF-8 was precipitated from the solution (overnight at 4OC) by addition of ethanol (2 volumes, OOC) and diethylether (4 volumes, OOC). The precipitate was collected by centrifugation.
SDS-PAGE was performed by the method of Mai~el.'~ Acidethanol soluble fraction was solubilized in an equal volume of sample buffer with 10% 2-mercaptoethanol and electrophoresed in 12.5% gels.
Immunoblotting was performed essentially as described by Towbin et a1. 26 Proteins were transferred to nitrocellulose (Schreicher & Schuel Co) overnight at 5OV with transblot cell.
The nitrocellulose membrane was incubated at room temperature Western blot analysis.
for 1 hour in phosphate-buffered saline (PBS) containing 7% nonfat dry milk (supplied by the Snow Brand Milk Co, Japan) to block nonspecific binding. As the primary antibody, we used anti-TGF-8 (Nl-15) IgG in a concentration of 80 pg/mL. Following the directions in the Vecstatin ABC kit, biotinylated anti-rabbit IgG was used as the second antibody, and after allowing it to react with a compound of avidin DH and biotinylated horseradish peroxidase, it was stained with diaminobenzidine tetrahydrochloride (DAB).
RESULTS
Activity to stimulate collagen synthesis of myelojbroblast in conditioned media from peripheral blasts of leukemia patients, and established leukemic cells. We studied the effects of megakaryoblast from a patient with AMKBL and MEG-01, an established cell line from AMKBLconditioned media, on the collagen synthesizing activity of myelofibroblasts ( Table 1) . We found that CM from megakaryoblasts did, in fact, promote the collagen synthesizing activity of myelofibroblasts, and that the increase in activity was concentration-dependent. The amount of collagen synthesis (dpm/105 cells) at the time of the addition of a 10% concentration of conditioned medium was 10.6 times greater than without this addition, representing a rate of increase from 6.3% to 25.4%. By the same token, the addition of CM from MEG-01 cells at a 10% concentration also activated collagen synthesis when compared with the control media. In this case, collagen synthesis was 9.6 times greater, resulting in a 27.8% increase in the collagen synthesis rate. For the sake of comparison, 10% concentrations of conditioned media from peripheral leukemic cells that had been taken from the four AML, AMoL, and ALL cases and from the three established leukemic cell lines (K562, KM3, and REM) were added to culturing media. In contrast to the nontreated media, the amount of collagen synthesis was 1.4 to 6.3 times greater. However, the effects of these latter tsignificantly different from the value for AM& (P < ,0021, ALL (Case 1) (P < .002), and ALL (Case 2) ( P < ,001).
$Significantly different from the value for K562 ( P < ,001). KM3 ( P < .001), and REH ( P < .005). §Significantly different from the value for KM3 (P < ,005) and REH ( P < .02).
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Although these represented an 18.4% increase for both growth factors in the rate of collagen synthesis, it still indicated a level of stimulation activity considerably weaker than that noted for TGF-@. Growth stimulation activity of myelofibroblasts in conditioned media of various leukemic-cell types. We first examined the results of how the media conditioned from the peripheral blood of each type of leukemia patient influenced myelofibroblast growth. The results are shown in Fig 2A. When the AMKBL megakaryoblast C M was compared with the plain medium (control) CM, the level of myelofibroblast growth was only slightly elevated, but this was roughly equivalent to or somewhat less than that for the C M from the peripheral leukemic cells of the four ALL, AML, and AMoL additions were still significantly less than the values found for AMKBL megakaryoblasts and MEG-01 cells.
We conducted similar investigations of TGF-@, PDGF, and EGF, the best known of the major growth factors in blood platelets (Fig 1) . Within a range of 0.064 to 0.4 ng/mL, the TGF-&stimulated collagen synthesis in myelofibroblasts was dose-dependent.
At the highest concentrations, 0.4 ng/mL, there was a 12.9-fold increase over that found when TGF-@ had not been added, while a t the same time, the collagen synthesis rate went from 6.3% to 30.5%. When 1.0 ng/mL concentrations of PDGF and E G F were added to the cultures, the amounts of collagen synthesized by myelofibroblasts were 8.9 and 4.4 greater, respectively, than without these growth factors.
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From cases. We examined the influence exerted by the C M from established leukemic cell lines on the growth of myelofibroblasts (Fig 2B) . When the MEG-01 C M was compared with the control, again, myelofibroblast growth had only slightly increased, but this was roughly equivalent to or somewhat less than that for established leukemic cell lines.
TGF-P activity in the conditioned media from leukemic cells. In order to determine the activity of TGF-P in the C M of peripheral leukemic cells and in the C M of established leukemic cell lines, we measured the colony-forming activity of N R K fibroblasts on soft agar cultures. Given the condition that EGF was not added at the same time, no colonies formed in any of the samples, but as Table 2 shows, when 2.5 ng/mL of EGF was added a t the same time, colony formation did, in fact, take place. In the C M with 10% concentrations of AMKBL megakaryoblasts and MEG-01 cells, there were 785 and 565 colonies per well, respectively. In those conditioned media with identical concentrations of peripheral leukemic cells from the four leukemia types and from the three established leukemic cell lines, colony numbers per well ranged from 78 to 188 per well. All colonyforming activity was inhibited by anti-N92-103 antibody.
Using the Northern blot method, we determined the level of TGF-0 mRNA expression itself in the megakaryoblasts of an AMKBL patient and in MEG-01 cells. As can be seen in Rehybridization of these same filters to a human y-actin cDNA probe did not show a significant variation in the corresponding mRNA levels among different cell samples. The amount of a mRNA was measured by densitometric scanning of the film. The ratios of TGF-P mRNA to y-actin mRNA were as follows: 1 .OO in AMKBL, 0.15 in AMOL, 1.25 in MEG-01, 0.26 in K562, and less than 0.05 in others. By means of the acid-ethanol method, the crude TGF-B fraction was extracted from 1 x lo7 samples of AMKBL megakaryoExpression of TGF-/3 mRNA in leukemic cells.
Detection of TGF-P polypeptide in leukemic cells. blasts, MEG-01 cells, AML, AMoL, and ALL peripheral leukemic cells and from the three established leukemic cell lines. These samples were subjected to the Western blot procedure. In Fig 4, for AMKBL megakaryoblasts and MEG-01 cells, we observed bands corresponding to approximately 13kd TGF-P monomers. The only other band observed was the slight AMoL band in lane 3.
Suppression by the arrti-N92-103 antibody of collagen syntheses of myelojibroblasts in conditioned media from AMKBL megakaryoblasts and MEG-Ol cells. The anti-N92-103 antibody, which had a neutralizing effect on TGF-@ activity, was added to the C M from AMKBL megakaryoblasts and MEG-01 cells in order to examine the effect it would have on their stimulatory activity for collagen synthesis by myelofibroblast. When anti-TGF-P IgG was added to the AMKBL megakaryoblast CM, there was a dosedependent decrease in the amount of collagen synthesis by myelofibroblasts (Table 3) . At the final concentration of 625 pg/mL, collagen synthesis was 62.4% less than for the nontreated group. The relative collagen synthesis rate also declined from 25.2% to 19.5%. A similar reduction in the amount of collagen synthesis by myelofibroblasts was found when C M of MEG-01, which had been preincubated with this antibody, was added to their culture media; the addition of IgG reduced collagen synthesis in proportion to the dose given. When 625 wg/mL were added, there was a 65.2% suppression of the level of activity found for the control group, with a drop in the collagen synthesis rate from 28.0% to 18.0%.
When nonimmune rabbit IgG was added to the AMKBL C M or MEG-01 CM, there were no effects on the collagen synthesis by myelofibroblasts.
DISCUSSION
The first mention of acute megakaryoblastic leukemia appears in the 1931 work of von Boros and K~r e n y i .~~ After the report by Lewis and Szur2' of a case of acute myelofibrosis in 1963, the question was raised as to the differences between these two diseases. However, only recently, Clare et a13 reported the significant finding that although the leukemic cells in AMKBL patients had chromosomal abnormalities, myelofibroblast karyotypes were of a normal type. The main cause of the worsening of the disease thus appeared to be the increase in the number of megakaryoblasts, while myelofibrosis could then be regarded as merely a secondary development. Therefore, it was hypothesized that the megakaryoblasts secrete some type of humoral factor that causes fibrosis by a paracrine manner. However, concrete proof based on obtaining the actual substance of such a humoral factor has thus far escaped research efforts.
I€ we consider megakaryoblasts to be the precursor cells of blood platelets, each type of growth factor contained within platelets should exist within megakaryoblasts as well. From this, it is not difficult to imagine these factors working as paracrine factors.
Of the growth factors in platelets, the one best known is the platelet-derived growth factor (PDGF), but although this factor accelerates the production of fibroblasts, it appears to be weak in terms of activating collagen synthesis.
Recently, TGF-/3 has been identified" as one of the ( 1 6 S 1 4 transforming growth factors in platelets, and its strength in activating the synthesis of collagen has been recognized."
From this vantage point, in the present research, we have evaluated the possible involvement of the TGF-8 derived from megakaryoblasts in myelofibrosis of AMKBL. First, we separated mononuclear cells (with a resulting blast rate of almost lOO%) from the peripheral blood of an AMKBL patient to examine the collagen synthesis activity of a conditioned medium of these cells, and observed that the degree to which these cells stimulated the activity was clearly dose-dependent. In order to confirm that this phenomenon is not specific for this case, we elevated the conditioned media from MEG-01, an established cell line from AMKBL, as above. The results indicated an equally high degree of strength in promoting collagen synthesis as that found in the 1 2 3 4 5 case of peripheral AMKBL cells. At the same time, the CM of peripheral leukemia cells from the other four AML, AMoL, and ALL cases and from the three established leukemic cell types showed considerably lower levels of collagen-stimulating activity than did the megakaryoblast CM.
Although Castro-Malaspina et al'' showed that megakaryocytes synthesize factors that stimulate myelofibroblast, in our study, growth-promoting activity in conditioned media from megakaryoblasts was not as distinct as other leukemic cells.
Next, we compared the ability to activate collagen synthesis characteristic of purified TGF-/3 with other growth factors arising in platelets, namely PDGF and EGF, with the result that our observations matched those found by Roberts et al." For personal use only. on October 23, 2017. by guest www.bloodjournal.org From We can conclude that TGF-,5' is the most powerful of all the factors that promote the synthesis of collagen.
We assessed the TGF-@ activity in media conditioned from AMKBL megakaryoblasts and from MEG-01 cells by the colony formation method with NRK fibroblasts as the target cells. There were 785 and 565 colonies per well in media from each of the different cells, respectively, but except for AMKBL, in the other leukemic cells (three types) and established leukemic cell lines (three types), no single well had more than 188 colonies. Consequently, it is clear that in C M from AMKBL megakaryoblasts and from MEG-01 cells, TGF-@ activity is greater than for C M from all other leukemic cells.
Since the TGF-P released by platelets and most other cancer cells is generally of an inactive type, it is necessary to activate it by some type of processing that uses acid.3' In the present experiments, since all of the TGF-@ activity observed in conditioned media occurred without any resort to this acid processing, we must conclude that the form of the TGF-@ released by the leukemic cells was already an active form, or that it became active immediately after its release. Similar observations that some types of malignant cells were indeed producing active TGF-6 were also reported recently.32s3' Now, it is not necessarily true that all of the component found in platelets is actually produced either by the platelets or by the megakaryoblasts; rather, some of the components are actually taken up by platelets from the blood itself.34 It is necessary to examine whether, even in the cases of media from both megakaryoblasts and MEG-01 cells, the TGF-@ is synthesized by the blasts themselves. When we used the Northern blot method to examine the mRNA released by each of the leukemic cell types with TGF-@ cDNA probes, there was considerably more TGF-@ mRNA expressed in the AMKBL and MEG-01 cases than in our four leukemia cases and three established cell lines.
Furthermore, when we used Western blotting to verify the translation of TGF-/3 mRNA expressed within the cells, stronger bands were observed in the AMKBL and MEG-01 cases than in the others. At such times, the TGF-@-specific antibody used followed the TGF-@ mRNA base s e q e u n~e , '~.~~ and we could postulate the antigenic determinants (Nl-15, N17-29, and N92-103). Of these, the N92-103 antibody was the antibody that suppressed TGF-@ activity (NRK colonyforming activity). It was then added to the AMKBL and MEG-01 conditioned media, and after it had neutralized TGF-@ activity, a count was taken and the rate of collagen synthesis by myelofibroblasts was investigated. The result was that levels of collagen synthesis of activity were suppressed by the antibody dose-dependently. Nevertheless, we may suppose that there exist some factors other than TGF-@ that cooperate with it to promote collagen synthesis. For example, although PDGF and EGF are comparatively weak, they do, in fact, promote collagen synthesis (Fig 1) . While there is no direct proof, there is sufficient evidence to suggest the possibility that they play an auxiliary role in bone marrow fibrosis.
When media conditioned from AMKBL megakaryoblasts and the MEG-01 cells were compared with purified TGF-8, because the maximum value for activity that stimulates collagen was apparently low (compare Table 1 and Fig l) , we can postulate that there is some substance mixed into the conditioned medium that suppresses TGF-@ activity.
In any case, even to the degree that we are unable to assert that TGF-@ is the sole causative substance, it may be reasonably correct to consider it the major cause of the bone marrow fibrosis occurring in AMKBL. According to Derynk et TGF-,5' expressed itself in an extremely wide range of cancer cells and tissues, and is in no way specific to AMKBL. In fact, in the present research into leukemic cells, other types of blasts in addition to AMKBL (while the amounts 
TGF-p INDUCED MYELOFIBROSIS IN AMKBL 1547
were very small) contained TGF-B activity, and the differences between the two were quantitative rather than qualitative. Not only in the case of AMKBL, but in other leukemias or cancers in which a high level of TGF-@ is manifest, it is very likely that tissue will also occur. In particular, an investigation of the expression of TGF-@ in scirrhous cancers, where there is a high degree of fibrosis with space infiltration of malignant tumors, is crucial to a full understanding of the relationship between TGF-8 and fibrosis.
TGF-P has been identified as the essential factor in cell transformation. However, recent research has paid considerable attention to the functions of TGF-@ other than cell transformation, and TGF-8 has been found to be multifunctional, exerting such activity as the promotion of collagen synthesis and suppression of cell proliferation.
In malignant tumors, various cytokines are produced to varying degrees, and each of these presents us with its own individual "face."
